Michael Nagle

Michael Nagle is an accomplished professional in the field of data sciences and human genetics, currently serving as the Executive Director and Head of Integrated Data Sciences at Eisai US since October 2020. Nagle leads a global R&D data sciences team engaged in human genetics, computational biology, and advanced analytics, contributing to critical insights in Neurology, Oncology, and Global Public Health. Prior to Eisai, Nagle held leadership roles at Pfizer, where significant contributions included implementing human genetics strategies and supporting target validation in various disease areas. Nagle's academic background includes a Ph.D. in Molecular Medicine and extensive research experience at Boston University School of Medicine, focusing on genetic risk variants in Parkinson's Disease.